Discontinue Chlorthalidone Immediately in Hypercalcemia
If a female patient is on chlorthalidone and develops hypercalcemia, the chlorthalidone must be discontinued immediately, as thiazide-like diuretics directly decrease calcium excretion and can cause or worsen hypercalcemia. 1
Why Chlorthalidone Causes Hypercalcemia
Chlorthalidone and other thiazide-like diuretics have a well-established mechanism of reducing urinary calcium excretion. The FDA drug label explicitly states: "Calcium excretion is decreased by thiazide-like drugs. Pathological changes in the parathyroid gland with hypercalcemia and hypophosphatemia have been observed in few patients on thiazide therapy." 1
This is not a rare occurrence—case reports document severe hypercalcemia reaching levels as high as 19.8 mg/dL and even 23 mg/dL in patients on chlorthalidone, particularly when combined with calcium supplements 2, 3. The syndrome is specifically termed "Calcium Alkali Thiazide Syndrome" (CATS) when thiazides are involved 2.
Immediate Management Steps
1. Stop the chlorthalidone immediately - This is non-negotiable as the drug is directly contributing to calcium retention 1
2. Check electrolytes urgently - The FDA label mandates periodic electrolyte monitoring for all patients on chlorthalidone, and this becomes critical in hypercalcemia 1
3. Assess severity of hypercalcemia:
- Mild: <12 mg/dL (3 mmol/L)
- Moderate: 12-14 mg/dL (3-3.5 mmol/L)
- Severe: >14 mg/dL (3.5 mmol/L) 4
4. Initiate standard hypercalcemia treatment:
- Aggressive IV hydration with normal saline
- Loop diuretics (furosemide) to enhance calcium excretion—note the irony that you're replacing one diuretic with another, but loop diuretics increase calcium excretion while thiazides decrease it 4, 2
- Consider bisphosphonates or calcitonin if severe 4
Alternative Antihypertensive Selection
Once hypercalcemia resolves, blood pressure control must be maintained with a different agent class. Do not restart chlorthalidone or any thiazide/thiazide-like diuretic.
Preferred alternatives based on guidelines 5, 6:
- ACE inhibitors or ARBs - First-line for most patients, especially if <55 years old
- Calcium channel blockers - Appropriate for patients >55 years or if ACE inhibitor/ARB contraindicated
- Loop diuretics (furosemide, torsemide) - If diuresis is specifically needed, as these increase rather than decrease calcium excretion 5
The 2017 ACC/AHA guidelines note that while chlorthalidone is generally preferred over hydrochlorothiazide for blood pressure control due to superior 24-hour coverage and cardiovascular outcomes 5, 6, this preference is completely negated in the setting of hypercalcemia where thiazides are contraindicated.
Critical Monitoring Points
The FDA label specifies that electrolyte monitoring should occur within 4 weeks of any diuretic initiation or dose change 7. In this patient who developed hypercalcemia on chlorthalidone, calcium levels should be rechecked 1-2 weeks after discontinuation to confirm resolution, then periodically thereafter on the new antihypertensive regimen.
Common Pitfall to Avoid
Do not simply reduce the chlorthalidone dose—complete discontinuation is required. The calcium-retaining effect is a class effect of all thiazide and thiazide-like diuretics, not dose-dependent in a way that allows safe continuation at lower doses in someone who has already developed hypercalcemia 1.